USFDA gives tentative nod to Alembic for Dronedarone tablets

Alembic has settled the case with Sanofi-Aventis and will launch its generic as per the terms of settlement, concluded the statement.

81
USFDA
Picture: Pixabay

Last Updated on January 13, 2022 by The Health Master

Alembic Pharmaceuticals today received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dronedarone tablets, USP, 400 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug (RLD) product Multaq tablets, 400 mg, by Sanofi-Aventis US LLC (Sanofi-Aventis), the company said in a statement.

Dronedarone is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation, it added.

Dronedarone tablets USP, 400 mg have an estimated market size of $500 million for twelve months ending September 2021 according to IQVIA.

Alembic has settled the case with Sanofi-Aventis and will launch its generic as per the terms of settlement, concluded the statement.

USFDA gives nod to Alembic Pharma for Vortioxetine tablets

USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease

USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets

USFDA gives tentative nod to Zydus Cadila for Pimavanserin capsules

USFDA gives tentative nod to Amphastar Pharma for Vasopressin injection

USFDA gives nod to Granules India for Prazosin HCL capsules

DCGI raises alarm over suspected spurious Tocilizumab injections in India

Drug recall: Clobetasol Propionate Ointment recalled due to this reason

3rd booster shot of Covaxin shows positive responses

FDA asks Chemists and Hospitals to ramp up medicine supply

India to become hub for Covid-19 antiviral medicines

15 New Drugs to be developed: Sanofi

DTAB agrees to amend Rules for OTC drugs and license displaying…

IPC releases 9th amendment list of 40 monographs to IP 2018

USFDA gives nod to Alembic Pharma for Vortioxetine tablets

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner